Diphenylamine

Diphenylamine

SCHEMBL23306702

N#Cc1ccc(N(c2ccccc2)c2ccccc2)cc1.c1ccc(Nc2ccccc2)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 3/20 0.46
ABCG2 Q9UNQ0 7/20 0.46
ABCB1 P08183 2/20 0.46
GSK3B P49841 1/20 0.46
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43
MAPK1 P28482 1/20 0.43
PTGS2 P35354 1/20 0.43
HTR2B P41595 1/20 0.43
KDM1A O60341 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865185 0.92 ALDH1A1 (0.46) CRHBPCRHR2ALDH1A1KDM4EGAA
SCHEMBL13748419 0.88 TSHR (0.59) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL13748038 0.88 TSHR (0.59) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL13748820 0.88 TSHR (0.59) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL8849586 0.88 TSHR (0.59) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL151680 0.88 TSHR (0.59) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL510240 0.84 ALDH1A1 (0.62) ALDH1A1KDM4EGAATSHRABCG2
SCHEMBL9481712 0.84 ALDH1A1 (0.62) ALDH1A1KDM4EGAATSHRABCG2
SCHEMBL15807463 0.82 TSHR (0.52) CRHBPCRHR2ALDH1A1KDM4ETSHR
SCHEMBL16484549 0.82 TSHR (0.52) CRHBPCRHR2ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230001119-A1 SYSTEMS AND METHODS FOR INCREASING NITROGEN MONOXIDE CONCENTRATION AND REMOVING NITROGEN DIOXIDE FROM A GAS STREAM Third Pole, Inc. (US) 2023-01-05 US disclosed
WO-2021087382-A1 SYSTEMS AND METHODS FOR INCREASING NITROGEN MONOXIDE CONCENTRATION AND REMOVING NITROGEN DIOXIDE FROM A GAS STREAM Third Pole, Inc. (US) 2021-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230001119-A1 SYSTEMS AND METHODS FOR INCREASING NITROGEN MONOXIDE CONCENTRATION AND REMOVING NITROGEN DIOXIDE FROM A GAS STREAM NOS2, NOS3, NOS1 CRHBP 1044/4885CRHR2 1523/4885ALDH1A1 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.